AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,130,000 | +101.8% | 74,712 | 0.0% | 0.22% | +125.8% |
| Q2 2022 | $560,000 | -17.6% | 74,712 | 0.0% | 0.10% | -3.0% |
| Q1 2022 | $680,000 | +29.8% | 74,712 | 0.0% | 0.10% | +35.1% |
| Q4 2021 | $524,000 | -15.2% | 74,712 | +37.8% | 0.07% | -19.6% |
| Q3 2021 | $618,000 | +19.1% | 54,212 | +67.3% | 0.09% | +22.7% |
| Q2 2021 | $519,000 | -10.4% | 32,405 | 0.0% | 0.08% | -13.8% |
| Q1 2021 | $579,000 | +32.2% | 32,405 | 0.0% | 0.09% | +17.6% |
| Q4 2020 | $438,000 | +52.6% | 32,405 | +32.8% | 0.07% | +37.0% |
| Q3 2020 | $287,000 | -20.3% | 24,405 | 0.0% | 0.05% | -22.9% |
| Q2 2020 | $360,000 | +9.4% | 24,405 | 0.0% | 0.07% | -4.1% |
| Q1 2020 | $329,000 | -44.2% | 24,405 | 0.0% | 0.07% | -23.2% |
| Q4 2019 | $590,000 | +45.3% | 24,405 | +15.7% | 0.10% | +20.3% |
| Q3 2019 | $406,000 | – | 21,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |